Invention Grant
- Patent Title: ERG targeted therapy
-
Application No.: US15924377Application Date: 2018-03-19
-
Publication No.: US10774122B2Publication Date: 2020-09-15
- Inventor: Arul Chinnaiyan , Xiaoju Wang
- Applicant: The Regents of the University of Michigan
- Applicant Address: US MI Ann Arbor
- Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Current Assignee Address: US MI Ann Arbor
- Agency: Casimir Jones, S.C.
- Agent Tanya Arenson
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K9/127 ; A61K47/60 ; A61K9/107 ; A61K47/54 ; A61K47/64 ; C07K14/82 ; A61K38/00
Abstract:
The present disclosure relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present disclosure relates to recurrent gene fusions as clinical targets for cancer.
Public/Granted literature
- US20180273595A1 ERG TARGETED THERAPY Public/Granted day:2018-09-27
Information query
